Davis's Drug Guide for Nurses | Mobile App & Web


Davis's Drug Guide for Nurses

17th edition

Author(s):

Publisher: F.A. Davis Company

ISBN 10: 171964005X

ISBN 13: 978-1719640053



Description At A Glance

Based on 17th print ed. - 1,400+ monographs covering 5,000 trade name & generic drugs. 150 drug classifications. 700+ built-in dosage calculators. 1200+ Audio pronunciations. Includes 1-year online access with WebView.

SAFETY FIRST!

Davis’s Drug Guide for Nurses® (DrugGuide™), Seventeenth Edition delivers all the information you need to administer medications safely across the lifespan—well-organized monographs for hundreds of generic and thousands of trade-name drugs. Includes one year of online access with WebView

HIGHLIGHTS

  • Search the complete 5,000-drug database and appendices quickly and efficiently.
  • Build your knowledge with extensively cross-referenced drugs.
  • Keep up to date with FDA drug news.
  • Audio pronunciations for almost 890 generic drugs
  • Over 700 built-in drug dosing calculation tools. Simply review a drug, calculate the dose and administer all in a single step without needing to switch to a separate drug dosing program.

Comprehensive coverage on over 1,400 drug monographs including more than:

  • 5,000 trade and generic drugs as well as expanded coverage of herbal products
  • 150 drug classifications, both therapeutic and pharmacologic (if available)
  • 500 commonly used combination drugs, including the dosage amount of the active generic ingredient
  • Most complete life-span drug dosing considerations for adult, pediatric, and geriatric patients

LIFE-SAVING GUIDANCE ... AT A GLANCE

  • New! The AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

#1 Drug Guide for patient safety - More High Alert Coverage and Patient Safety Information than any other drug guide including:

  • Special highlights to identify High Alert Medications with high risks for patient injury and information throughout the monograph that explain what the nurse can do to ensure patient safety
  • "Do not confuse with" and "Do not crush, break, or chew" caution statements highlighted to support safe practice
  • Information on how to prevent administration errors, detect dosing and dispensing errors, and detect or prevent adverse drug reactions (ADR)s.
  • Explanations on how to administer medication safely by all routes – including signs and symptoms for toxicity and overdose, safe handling tips and how to educate patients for safe medication use in the home
  • High alert medications - in-depth high alert and patient safety coverage
  • Red, capitalized letters for life-threatening side effects
  • REMS (Risk Evaluation and Mitigation Strategies) icon
  • Drug-drug, drug-food, drug-natural product interactions
  • Special considerations for patient populations.
  • Geri heading identifies special concerns for older adults.
  • OB and Lact headings highlight information for pregnant and breastfeeding patients.
  • Pedi heading identifies concerns for children.
  • Rep heading identifies considerations for patients of reproductive age.
  • IV Administration subheads
  • Pharmacogenomic content
  • Canadian-specific content
  • In-depth guidance for patient and family teaching
  • NDC (National Drug Code) for 1300+ Monographs.

Expanded coverage on vulnerable populations including:

  • Indications and dosing recommendations for top 100 pediatric drugs
  • Pediatric, geriatric, and OB medication administration considerations
  • A complete immunization schedule
  • Special techniques for administering medications to children
  • Oral rehydration solutions
  • Drugs and breast feeding
  • List of drugs associated with increased number of falls in the elderly
{davisdrugs2020-17:3499}

Your Voice

By Rosie Augustin
Chat Support worked!
Skyscape Executive are the best!

Share Via

KEEP IN TOUCH

     

Subscribe

Copyright © 2020. All rights reserved. Skyscape® is the registered trademark of Skyscape Medpresso, Inc.
All other trademarks, service marks and registrations are the intellectual properties of their respective owners.